At Biocomposites, we are pioneering calcium compound devices to regenerate bone and carry antibiotics in bone and soft tissue. With over 30 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.
Our innovative calcium compound devices range from bone grafts to antibiotic carriers for use in bone and soft tissue. Possessing unique characteristics for regenerating bone and managing infected sites, our products are opening new possibilities for surgeons around the world.
Our products are tried and trusted around the world to change lives. We believe that much of our success, in over 40 countries worldwide, is due to the confidence our surgeons have in our quality control – enabling us to create products of unrivaled quality and performance.
Biocomposites has been honoured with two awards recognising our excellence in Innovation and International Trade. Announced annually by Her Majesty The Queen, the awards recognise outstanding achievement by UK businesses.
“Biocomposites identified a significant need to reduce the infection rates from hip and knee replacement surgery. In response they developed STIMULAN Rapid Cure, the first and only calcium sulfate antibiotic carrier that is approved for use in infected bone and soft tissue. The beads in the product deliver an increased level of antibiotics direct to the site of infection and because they absorb as the antibiotic elutes there is no need for further follow-up procedures for the patient.”
“Biocomposites’ products are used in over 120,000 procedures every year and is the only supplier providing calcium sulfate antibiotic carriers for use in bone and soft tissue to the NHS. Overseas sales grew by over 200% in a six-year period from 40 countries including the United States, the Netherlands, China, Canada and India.”
With a singular focus on developing innovative calcium compound medical devices, Biocomposites has gained a deep expertise in musculoskeletal infections, trauma, spine, foot and ankle, and sports injuries. Connected with universities and hospitals around the world, Biocomposites continues to innovate in infection management to support surgeons and their patients.
We pride ourselves on our power to innovate. This focus and ongoing investment in proprietary technologies has driven our teams to push the frontiers of calcium compound medical devices at every stage – with over 100 grants and registrations of IP, a strong R&D pipeline, and a string of world firsts.
We understand the importance confidence plays in selecting surgical devices. This is why we underpin all our product development with a dedication to quality. Quality people, processes and safeguards that meet and exceed medical standards, right through manufacturing, processing, testing and distribution. All handled in-house to ensure reliable, predictable and reproducible clinical performance.